Hyleen Capital

Hyleen deploys across seed, start-up, growth, and PIPE transactions, effectively covering the full Chinese private-company lifecycle from formation to pre-IPO. This full-stack approach allows the firm to follow winners from early venture rounds through later-stage capital raises. PIPE capability also provides a pathway into public markets when portfolio companies list in Hong Kong or mainland exchanges.

The portfolio concentrates on enterprise software, artificial intelligence and machine learning, healthcare services, and mobility — hard-tech and productivity themes rather than consumer internet or platform plays. Known positions include autonomous driving chipmaker Horizon Robotics, AI firm Megvii, and edtech platform Yuanfudao, all reflecting a thesis that China's next growth phase will be driven by automation and enterprise digitization.

There is no public evidence that Hyleen participates in co-investment syndicates with external general partners or accepts capital from outside limited partners. The firm's deal structures appear to rely on direct equity and convertible instruments funded by proprietary capital. Whether that capital originates solely from Zhang Lei, from Hillhouse-affiliated entities, or from a discreet LP base remains undisclosed.

Hyleen has maintained minimal public profile since 2023. Portfolio company Horizon Robotics filed for a Hong Kong IPO in 2024, and Yuanfudao underwent significant restructuring following China's 2021 crackdown on for-profit tutoring — both events materially affecting Hyleen's holdings. The firm has issued no press releases, disclosed no new fund closes, and announced no new deals in the past 24 months.